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ABSTRACT
Background: Mortality from asthma in Japan still
remains at a higher level than in Europe and America
and how to decrease that mortality rate is an important
issue. For the prevention of death from asthma, it is
essential to study the risk factors. However, there has
been almost no such study performed in Japan and,
for this reason, we performed the present study to 
elucidate the background of the recent cases of death
from asthma.
Methods: This study was performed on cases of death
from asthma at the Tokyo Medical Examiner’s Office
over a period of 5 years (1993–1997).
Results: There were 456 cases under study, with the
age at death ranging from 4 to 96 years (average age
58.5 years). The male to female ratio was 1.8 : 1 and
there was a tendency for a marked increase in the
number of cases of death from asthma in women aged
60 years and older. The annual number of deaths was
lowest in 1997, being 67 cases. The monthly number
of deaths was higher in December and February and
was lower in the months of June, July and September.
Among the cases investigated, 60.2% died within 3 h
after the onset of an asthmatic attack. In the cases of
patients living alone, the chance of receiving emer-
gency medical care was significantly lower compared
with cases where patients lived with other people. Of
the cases of death from asthma, 36.6% of patients
were in the habit of drinking and 27.7% smoked. In an
investigation of the 247 deaths that occurred during
the 3 year period from 1995 to 1997, there were 140
cases (56.7%) for which emergency medical care was
offered to treat the asthmatic attack. In 126 cases
(90.0%), cardiopulmonary arrest was observed on
arrival at hospital. Of these cases, a heart beat was
restored in 27 patients (21.4%). In 133 of 456 deaths
(29.2%), patients had used a metered dose inhaler
(MDI). Among these cases, 80 patients (60.2%)
seemed to have been using a MDI up to the time
immediately before death.
Conclusions: Those living alone have a significantly
lower likelihood of receiving emergency medical care
immediately before death compared with those living
with other people. The cases of acute death within 3 h
after the onset of the asthma attack accounted for
60.2% of all cases and this seems to be important for
future studies of the medical care of deaths due to
asthma.
Key words: asthma death, bronchial asthma, living
alone, metered dose inhaler, risk factor.
INTRODUCTION
According to a dynamic statistics survey of population
data from the Japanese Ministry of Health, Labour and
Welfare regarding the tendency of death from asthma in
Japan, mortality in the cases of asthma per 100 000
population steadily decreased until approximately 1975.
However, since then, mortality has remained almost at
the same level and the number of deaths per 100 000
population was 4.3 persons in 1999. However, this is still
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relatively high compared with mortality in cases of
asthma in Europe and America, which is approximately 
2 persons per 100 000 population.1 How to decrease the
number of deaths from asthma is still a serious problem.
With the purpose of elucidating the actual status and
the cause of death in patients who died from asthma and
also of contributing to the prognosis and treatment of
patients with bronchial asthma, we performed an investi-
gation on the cases of death from bronchial asthma
based on data at the Tokyo Medical Examiner’s Office.
The results of our study are reported here.
METHODS
The study was performed on the cases for which a post-
mortem examination and autopsy were performed at the
Tokyo Medical Examiner’s Office during the 5 year
period from 1993 to 1997. The post-mortem examina-
tion statement and autopsy record were studied.
The Tokyo Medical Examiner’s Office serves the 23
wards of the Tokyo Metropolitan Area as an administra-
tive agency to determine the cause of death in cases
where death is not due to natural causes or where the
cause of death is not clear. When the cause of death
cannot be clarified by external examination alone, an
administrative autopsy is performed at the Medical
Examiner’s Office.
In preparing the post-mortem examination statement,
after police officers have investigated the data, such as
past history, present history, condition of death etc., an
assistant police inspector or a police officer of higher
rank and a doctor examine the corpse together. Then, the
doctor prepares the post-mortem examination statement
based on these data.
RESULTS
Age and sex of the cases of death from asthma
The study was performed on 456 cases (294 male and
162 female), including 339 cases of cadaver inspection
(212 male and 127 female) and 117 cases of autopsy
(82 male and 35 female). Age at death ranged from 4 to
96 years (average age 58.5 years). The male to female
ratio was 1.8 : 1. Up until patients reached their 50s,
there were considerably more asthma deaths in males,
whereas there was a tendency for a marked increase in
the number of cases of death from asthma in women
aged 60 years and older. Death from asthma showed a
small increase in patients in their 20s, but decreased
among patients in their 30s and increases markedly
again among patients in their 50s. Thus, a two-peak
pattern was seen (Fig. 1).
Transition of asthmatic deaths classified by
year and month
The number of deaths classified by year was as follows:
98 cases (68 male and 30 female) in 1993; 104 cases
(65 male and 39 female) in 1994; 94 cases (55 male
and 39 female) in 1995; 93 cases (61 male and 32
female) in 1996; and 67 cases (45 male and 22 female)
in 1997 (Fig. 2).
The number of asthmatic deaths classified by month
was as follows: 42 cases in January (24 male and 18
female); 47 cases in February (30 male and 17 female);
36 cases in March (24 male and 12 female); 37 cases in
April (21 male and 16 female); 43 cases in May (28 male
and 15 female); 29 cases in June (19 male and 10
female); 31 cases in July (23 male and eight female); 36
cases in August (19 male and 17 female); 28 cases in
September (17 male and 11 female); 41 cases in October
(28 male and 13 female); 39 cases in November 
(28 male and 11 female); and 47 cases in December 
(33 male and 14 female; Fig. 3).
Conditions of death
An investigation was performed on 216 cases in which
the time from the final asthmatic attack to death was
known precisely. The results were as follows: the patient
died within 1 h in 17 cases (7.9%); within 1–3 h in 113
cases (52.3%); within 3–6 h in 30 cases (13.9%); within
6–12 h in 24 cases (11.1%); and over 12 h after the final
attack in 32 cases (14.8%; Fig. 4).
The time of the last attack was defined as the time
when wheeze (stridor) did not improve up to the time
when death occurred and this was judged retrospectively.
Conditions at home
In 379 cases in which it could be determined whether 
the patient was living with other people, it was found that
the patient was living alone in 160 cases (42.2%), living
with a spouse in 36 cases (9.5%) and living with two or
more other people in 179 cases (47.2%). Data were
unknown in four cases (1.1%; Fig. 5).
Relationship between the number of people
living with the patient and the chance of
receiving emergency medical care
The study also examined 204 cases for which there were
records on others living with the patient and the chance
of the subject receiving emergency medical care. Among
the 68 cases in which the patient was living alone, 19
patients received emergency medical care and 49
patients did not receive emergency medical care. Of the
36 cases in which the patient was living with a spouse, 23
cases received emergency medical care and 13 cases did
not. In 100 cases in which the patient was living with two
or more other people, 73 cases received emergency
medical care and 27 did not. In cases where the patient
was living alone, the chance to receive emergency
medical care was significantly lower compared with cases
where the patient was living with other people
(P < 0.0001; Fig. 6).
Drinking and smoking
There were records about drinking habits for 279 cases
and records about smoking for 292 cases. Among these,
patients drank in 102 cases (36.6%) and smoked in 81
cases (27.7%).
The drinking habits of the patients were investigated 
in more detail. In 43 cases (15.4%), patients drank 
occasionally, 43 (15.4%) drank 180–540 mL alcoholic
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Fig. 1 Age distribution of asthma deaths. The study was performed on 456 cases, including 294 males ( ) and 162 females (),
with age at death ranging from 4 to 96 years (average age 58.5 years). The male to female ratio was 1.8 : 1.
Fig. 2 Annual asthma death cases investigated at the Tokyo
Medical Examiner’s Office. The annual number of death cases
was lowest in 1997, being 67 cases. ( ), males; (), females.
beverages (the alcoholic content of Japanese sake is
roughly equivalent to wine) almost every day, seven cases
(2.5%) drank 720–1080 mL almost every day and six
cases (2.2%) drank 1080–1620 mL almost every day
(Fig. 7).
When the smoking habits of the patients were investi-
gated in more detail, 14 patients (4.8%) smoked 1–9
cigarettes/day, 20 patients (6.8%) smoked 10–19 cigarettes/
day, 35 patients (12.0%) smoked 20–29 cigarettes/day,
one patient (0.3%) smoked 30–39 cigarettes/day, nine
patients (3.1%) smoked 40–49 cigarettes/day, one patient
(0.3%) smoked ≥ 50 cigarettes/day and data were not
available in one case (0.3%; Fig. 8).
In post-mortem examination statements prepared since
1995, it has been essential to describe the drinking and
smoking history of the deceased.
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Fig. 3 Monthly asthma death cases investigated at the Tokyo Medical Examiner’s Office. The monthly number of deaths was
higher in December and February and was lower in June, July and September. ( ), males; (), females.
Fig. 4 Duration of asthma attack before death. An investiga-
tion was performed on 216 cases in which the time from the
final asthmatic attack to death was known precisely.
Fig. 5 Number of family members. A total of 379 cases were
classified according to the number of family members living
with the patients.
Emergency medical care
Of the 247 cases during the 3 year period from 1995 to
1997, 140 cases (56.7%) patients received emergency
medical care for an asthmatic attack and 126 patients
(90.0%) had cardiopulmonary arrest on arrival at hospi-
tal. Among the latter cases, heart beat was restored after
emergency medical procedures in 27 cases (21.4%).
Treatment
In the survey for the 5 year period from 1993 to 1997,
133 patients (29.2%) had records using a metered dose
inhaler (MDI) in 456 cases. Of these, 80 patients (60.2%)
seemed to have been using the MDI immediately before
death.
The details of MDI use were as given below, except 
for 72 cases in which data were not available: fenoterol
hydrobromide was used in 22 cases (most frequently
used), followed by salbutamol sulfate (used in 10 cases),
procaterol hydrochloride (used in seven cases), a mix-
ture of isoprenaline sulfate–atropine methylbromide–
dexamethasone (used in five cases), orciprenaline sulfate
(used in three cases), a mixture of isoprenaline hydro-
chloride–phenylephrine hydrochloride (used in one case),
isoproterenol hydrochloride (used in one case) and
oxitropium bromide (used in five cases).
DISCUSSION
When an investigation was performed on the relationship
between asthmatic death and sex, the male to female
ratio was 1.8 : 1, showing a higher rate in male patients.
This agrees with past data in Japan,2 which indicates a
higher incidence of asthma in male patients. However,
there are some reports that such gender differences in
asthmatic deaths have been disappearing in recent
years.3,4
Regarding the age of the patients at the time of death,
the number of deaths increased in patients in their 20s,
while the number of deaths decreased in patients in their
30s. The number of deaths increased again in patients in
their 50s, exhibiting a two-peak pattern. In particular,
asthmatic deaths of patients in their 20s was found in 40
cases (8.8%). Of these, 36 (90.0%) were male patients. 
A survey on death from asthma in adult patients by
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Fig. 6 Living condition and emergency medical care before
asthma death. In cases of patients living alone, the chance to
receive emergency medical care prior to death was significantly
lower compared with cases in which the patients lived with
other people. ( ), + emergency care; ( ), – emergency care.
Fig. 7 Drinking habits of the asthma death cases. Drinking
habits of 279 cases were available. Of these, 36.6% of patients
drank every day.
Fig. 8 Smoking habits of asthma death cases. Smoking
habits of 292 cases were available. Of these, 27.7% of patients
were everyday smokers.
Nakazawa et al.3,4 and the report by the Japanese
Ministry of Health, Labour and Welfare5 also point out the
increase in the number of deaths among younger male
patients over the past several years and this indicates a
grievous situation. This can be attributed to social factors,
psychological factors and irregularity of medical exami-
nations, but the precise reasons are not known and
further investigations should be undertaken.
Next, the study examined the conditions of death in
216 cases for which the time from the final asthmatic
attack to death was known precisely. In these cases,
60.2% of patients died within 3 h after the onset of the
attack and this reveals the importance of adequate treat-
ment for acute attacks.
A direct cause of the death from asthma has not yet
been clearly elucidated. For a long time, the cause of the
death from asthma was attributed to either cardiac death
due to arrhythmia or death due to suffocation caused by
airway obstruction. However, in 1991, Molfino et al.6
reported that, among patients who were saved by artifi-
cial ventilation in severe asthmatic attacks (near-death
cases), severe arrhythmia was not found even immedi-
ately after the life-saving procedure and death from
asthma was not caused by cardiac arrest but, rather, by
respiratory arrest (or suffocation).6 It is generally believed
now that most asthmatic deaths are caused by respiratory
arrest. In addition, Kikuchi et al.7 reported that, of the
near-fatal asthma patients, there were some cases where
the chemosensitivity of the patients to hypoxia was
reduced and perception of dyspnea was blunted. Until
now, it has been believed that death from asthma occurs
as follows: due to a severe asthmatic attack, extensive
airway stenosis develops rapidly. As a result, respiratory
insufficiency advances quickly and the patient dies before
receiving medical care at a hospital. However, in recent
years, such cases are rather rare and it is considered that
asthmatic death mostly occurs as follows: when the blood
gas condition is aggravated due to an asthmatic attack,
the compensating mechanism to the hypoxic state is not
powerful enough and respiratory insufficiency rapidly
advances and is aggravated, leading to death. In addi-
tion, there are cases where the sensitivity of the patient 
to dyspnea is low and the patient does not visit the hos-
pital until the conditions are aggravated, even when an
asthmatic attack occurs, and the patient dies. In the
future, it seems essential to precisely and objectively
determine to what degree the patient is affected by the
disease using such means as examination of expiratory
peak flow. It is also important to educate patients by them
with knowledge of the disease. Such efforts will be helpful
and will contribute to decrease the number of deaths
from asthma.
One of the factors that causes frequent death from
asthma may be the fact that many patients are now living
alone (i.e. 42.2% of deaths in the present study) and this
means that the patient cannot take adequate action at
the time of an asthmatic attack. Thus, lifestyle may be one
of the factors causing the increase in the number of
deaths from asthma.
In the present study, patients drank in 36.6% of cases
and there were 14 cases (3.1%) in which the patients had
severe attacks after drinking a large quantity of alcoholic
beverage. It is considered that the causes of alcohol-
induced asthma include the direct effects of ethanol and
acetaldehyde (i.e. a metabolite of ethanol) on the airway.
Regarding the action of ethanol on the airway, Myou
et al.8 reported that, when a patient with alcohol-induced
asthma was given alcohol at a concentration as high as
20%, airway constriction occurred, but when the concen-
tration of alcohol was gradually increased, airway con-
striction did not develop but, rather, hypersensitivity of 
the airway improved. Furthermore, Ayres et al.9 noted
that when patients gradually drank 60% ethanol, airway 
dilation was seen in four of five patients with asthma.
However, when patients drank the ethanol in one shot,
airway constriction developed immediately or after several
minutes. Ayres et al.9 suggested that this may be because
irritant receptors in the upper airway are stimulated by
ethanol. Regarding the effect of acetaldehyde on the
airway, Shimoda et al.10 noted an increase in the 
concentration of acetaldehyde and histamine in patients
with alcohol-induced asthma. Furthermore, based on
their experimental results with guinea pigs and patients
with asthma, Myou et al.11,12 reported that inhalation of
acetaldehyde induced airway constriction through the
release of histamine. Because acetaldehyde releases 
histamine from the leukocytes of patients with asthma,
Myou et al. suggest that, as acetaldehyde is accumu-
lated, histamine is released from macrophages in the
blood or from basophils and airway constriction develops.
Furthermore, according to the guidelines of the National
Institutes of Health (NIH), patients who have asthmatic
symptoms after drinking beer or wine may have severe
asthmatic attacks caused by sulfites contained in such
beverages and it is suggested that special care must be
taken in such cases.13
If patients have bronchial asthma, they may be fully
aware of the risk of smoking. In the present investigation,
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27.7% of all patients had been smoking and this ratio
was approximately the same as the smoking ratio of the
Japanese population in general.14 Smoking not only stim-
ulates the vagus nerve and increases activity of tachykinin
and causes airway constriction, but also induces inflam-
mation in the airway.15–17 Regarding exacerbation of
asthma, Marquette et al.18 reported that in a cohort 
of 147 patients with near-fatal asthma, those with a
smoking habit had to be sent more frequently to hospital
again. Furthermore, they reported that the mortality over
a 6 year period among patients who smoked was 28%
compared with 9% among non-smoking patients,
showing significantly higher mortality in the smokers.
Pedersen et al.19 divided 85 patients with asthma into
three groups and these patients were treated either with
low-dose budesonide (400 µg/day), high-dose budes-
onide (1600 µg/day) or theophylline (66 mg/day) for
11 months. The results showed that, in the high-dose
budesonide group, the blood content of eosinophil cati-
onic protein and eosinophil protein X/eosinophil derived
neurotoxin decreased and forced expiratory volume 
in 1 s increased. In addition, improvement of hyper-
sensitivity of the airway was noted, but such signs of
improvement were found only in the non-smoking patients.
Pedersen et al.19 reported that there was no sign of
improvement among the smokers, even when they were
treated with high-dose budesonide. These results suggest
that smoking is a factor that exacerbates asthma already
developing, increases the frequency of attacks, attenu-
ates therapeutic effects and raises the risk of asthmatic
death, and that efforts must be made to get patients to
refrain from smoking.
There has been controversy on the relationship
between death from asthma and MDI. In the present
study, it was found that a MDI was used in 29.2% of
cases. Of these, 60.2% of patients were using a MDI up
to the time immediately before death. With regard to the
use of MDI, not counting the 72 cases for which detailed
data were not available, fenoterol hydrobromide was
used in 22 cases and this was most frequently used. The
relationship between β-adrenergic receptor agonist
inhalant and asthmatic death has been discussed for
many years. Inman et al.20 first announced in 1969 that
asthmatic death in England and Wales was correlated
with the sale of isoproterenol. In 1989, Crane et al.21
reported in their controlled survey on the cases in New
Zealand that the risk of asthmatic death was high among
patients who used fenoterol. In addition, in 1995, Pearce
et al.22 noted that the increase in asthmatic deaths in 
New Zealand from the late 1970s to the 1980s was
apparently correlated with the results of the sale of
fenoterol and expulsion of fenoterol from the pharma-
ceutical market has led to a rapid decrease in the number
of asthmatic deaths in New Zealand. In contrast, Garett
et al.23 argued that the increase in asthmatic deaths may
be attributed to the frequent use of fenoterol to treat
severe cases. Garett et al.23 point out that the increase in
the number of asthmatic deaths in the 1970s could be
attributed to the fact that economic depression in New
Zealand led to a decrease in the quality of treatment for
asthma, whereas the decrease in the number of asthmatic
deaths in the 1980s was brought about by an improve-
ment in the quality of medical treatment based on inhala-
tion steroids. To support this, Boman et al.24 announced 
at the American Thoracic Society in 1997 that, in Sweden,
asthmatic deaths decreased approximately one-eighth in
the past 10 years (i.e. to approximately 0.1 per 100 000
population) in correlation with the propagation of the use
of inhalation steroids and no correlation with the sale 
of fenoterol was observed. Suissa et al.25 reported from
the results of a cohort analysis in Canada that, when 
1.4 or more canisters of MDI containing 20 000 µg 
β-adrenergic receptor agonist were used each month,
the risk of asthmatic death increased rapidly. Further-
more, Spitzer et al.26 verified that, when a patient used
one canister or more of beclometasone each month, the
risk of fatal or semifatal asthma apparently decreased.
Similarly, Sly et al.1 described that decreases in asthma
mortality in New Zealand were much more closely
associated with substantial increases in sales of inhaled
corticosteroids than with decreases in sales of feno-
terol. Instead of using a β-adrenergic receptor agonist 
excessively, daily use of an inhalation steroid as an anti-
inflammatory treatment must be considered.
Clinicians must make every effort in the early detection
of risk factors for asthmatic death and try to improve the
quality of education for their patients, especially those
living alone. This seems to be important for future studies
of medical care of acute asthmatic death cases, because
such cases, dying within 3 h after the onset of an attack,
accounted for 60.2% of all acute deaths.
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